Skip to Content
Developmental Therapeutics Program (DTP)
Contact DTP
Show menu
Search this site
Last Updated: 9/20/18

Office of the Associate Director (OAD)

DTP provides resources and services to both public and private research communities, maintains a robust infrastructure for anti-cancer drug discovery and development, and manages a large portfolio of grants pertinent to drug discovery and biochemical pharmacology. Upon request, DTP also provides advice on drug development issues regarding chemistry, manufacturing & control, pharmacology & toxicology, and IND requirements.

DTP/OAD provides planning, implementation, coordination and oversight for all DTP activities.

OAD Staff:

Name Position Email
Dr. Jerry M. Collins Associate Director
Dr. Rose Aurigemma Deputy Associate Director
Dr Paul G Grothaus Chemist
Dr. Brian D. Peyser Special Assistant to DTP Associate Director
Dr. Michael Currens Special Assistant to DTP Associate Director
Bernadette Carter Program Assistant

About the Associate Director

Jerry M. Collins, Ph.D. Jerry M. Collins, Ph.D., is an internationally recognized pharmacologist. He has been closely associated with NCI’s drug development efforts for more than 25 years, first as an NCI intramural investigator and then as the Chief of the Pharmacokinetics Section. More…